| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |